Skip to main content
logo
Celltrion, Inc. (KRX:068270)
South Korea flag South Korea · Delayed Price · Currency is KRW
202,500
+21,500 (11.88%)
At close: Jan 2, 2026

Revenue

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212013 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 2013 - 2020
Biopharmaceutical Medicines Revenue
6.66T6.07T
Log In
Log In
Log In
Upgrade
Chemical Medicines Revenue
517.00B531.39B
Log In
Log In
Log In
Upgrade
Other Segments Revenue
7.24B5.82B
Log In
Log In
Log In
Upgrade
Adjustments to Revenue
-3,438.85B-3,050.04B
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212013 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 2013 - 2020
Domestic Revenue
1.48T1.55T
Log In
Log In
Log In
Upgrade
Americas Revenue
--
Log In
Log In
Log In
Upgrade
Asia Revenue
211.23B192.46B
Log In
Log In
Log In
Upgrade
Europe Revenue
1.65T1.50T
Log In
Log In
Log In
Upgrade
North America Revenue
279.01B168.09B
Log In
Log In
Log In
Upgrade
Central and South America Revenue
123.60B140.96B
Log In
Log In
Log In
Upgrade

EBIT

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212013 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 2013 - 2020
Biopharmaceutical Medicines Operating Income
1.47T1.20T
Log In
Log In
Log In
Upgrade
Chemical Medicines Operating Income
14.11B9.18B
Log In
Log In
Log In
Upgrade
Other Segments Operating Income
1.37B505.60M
Log In
Log In
Log In
Upgrade
Adjustments to Operating Income
-693.18B-716.79B
Log In
Log In
Log In
Upgrade
Updated Jun 30, 2025. Data Source: Fiscal.ai.